| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CYTOKINETICS INC | EVP, Chief Commercial Officer | Common Stock | 63.9K | $4.27M | $66.88 | Mar 14, 2024 | Direct |
| CYTOKINETICS INC | EVP, Chief Commercial Officer | Non-Qualified Stock Option (Right to Buy) | 18.3K | Mar 14, 2024 | Direct | ||
| CYTOKINETICS INC | EVP, Chief Commercial Officer | Incentive Stock Option (Right to Buy) | 1.22K | Mar 14, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | Mar 14, 2024 | 3 | $0 | 4 | Mar 18, 2024 | EVP, Chief Commercial Officer |
| CYTK | CYTOKINETICS INC | Mar 4, 2024 | 2 | -$490K | 4 | Mar 7, 2024 | EVP, Chief Commercial Officer |
| CYTK | CYTOKINETICS INC | Mar 6, 2023 | 3 | $0 | 4 | Mar 7, 2023 | EVP, Chief Commercial Officer |
| CYTK | CYTOKINETICS INC | Mar 2, 2023 | 1 | -$87.2K | 4 | Mar 3, 2023 | EVP, Chief Commercial Officer |
| CYTK | CYTOKINETICS INC | Feb 16, 2023 | 1 | -$42.8K | 4 | Feb 17, 2023 | EVP, Chief Commercial Officer |
| CYTK | CYTOKINETICS INC | Mar 2, 2022 | 3 | $1.69M | 4 | Mar 3, 2022 | EVP, Chief Commercial Officer |
| CYTK | CYTOKINETICS INC | Feb 16, 2022 | 2 | $0 | 4 | Feb 17, 2022 | EVP, Chief Commercial Officer |